Molecular comparison of interval and screen-detected breast cancers
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular comparison of interval and screen-detected breast cancers
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-12
DOI
10.1002/path.5251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast cancer brain metastases show increased levels of genomic aberration based homologous recombination deficiency scores relative to their corresponding primary tumors
- (2018) M Diossy et al. ANNALS OF ONCOLOGY
- Molecular analysis of PALB2 -associated breast cancers
- (2018) Jue Er Amanda Lee et al. JOURNAL OF PATHOLOGY
- Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility
- (2018) Simone M. Rowley et al. GENETICS IN MEDICINE
- Mutations in RECQL are not associated with breast cancer risk in an Australian population
- (2018) Na Li et al. NATURE GENETICS
- Association analysis identifies 65 new breast cancer risk loci
- (2017) Kyriaki Michailidou et al. NATURE
- ClinVar: improving access to variant interpretations and supporting evidence
- (2017) Melissa J Landrum et al. NUCLEIC ACIDS RESEARCH
- ClinVar Is a Critical Resource to Advance Variant Interpretation
- (2017) Heidi L. Rehm et al. ONCOLOGIST
- ASH1L histone methyltransferase regulates the handoff between damage recognition factors in global-genome nucleotide excision repair
- (2017) Chiara Balbo Pogliano et al. Nature Communications
- Reevaluation of RINT1 as a breast cancer predisposition gene
- (2016) Na Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes
- (2016) Jingmei Li et al. CLINICAL CANCER RESEARCH
- Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
- (2016) M. L. Telli et al. CLINICAL CANCER RESEARCH
- Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
- (2016) Ella R. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer
- (2016) Nadine Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of protein-coding genetic variation in 60,706 humans
- (2016) Monkol Lek et al. NATURE
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
- (2016) Bernard Pereira et al. Nature Communications
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients
- (2015) Xiaosong Chen et al. BMC CANCER
- A comparison of clinical–pathological characteristics between symptomatic and interval breast cancer
- (2015) B. Meshkat et al. BREAST
- Risk Factors and Tumor Characteristics of Interval Cancers by Mammographic Density
- (2015) Johanna Holm et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
- (2015) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- CopywriteR: DNA copy number detection from off-target sequence data
- (2015) Thomas Kuilman et al. GENOME BIOLOGY
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
- (2015) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
- (2014) J. Li et al. ANNALS OF ONCOLOGY
- Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications
- (2014) Andy Rimmer et al. NATURE GENETICS
- Impact of Risk Factors on Different Interval Cancer Subtypes in a Population-Based Breast Cancer Screening Programme
- (2014) Jordi Blanch et al. PLoS One
- Gene Expression Profiling in True Interval Breast Cancer Reveals Overactivation of the mTOR Signaling Pathway
- (2013) F. Rojo et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
- (2012) V Abkevich et al. BRITISH JOURNAL OF CANCER
- Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation
- (2012) T. Popova et al. CANCER RESEARCH
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
- (2012) D. C. Koboldt et al. GENOME RESEARCH
- Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening
- (2012) A. Caldarella et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Human Epidermal Growth Factor Receptor 2 Status and Interval Breast Cancer in a Population-Based Cancer Registry Study
- (2012) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- A Review of Interval Breast Cancers Diagnosed among Participants of the Nova Scotia Breast Screening Program
- (2012) Jennifer I. Payne et al. RADIOLOGY
- Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
- (2012) Nicolai J. Birkbak et al. Cancer Discovery
- Independent Prognostic Value of Screen Detection in Invasive Breast Cancer
- (2011) Stella Mook et al. JNCI-Journal of the National Cancer Institute
- Tumor Characteristics Associated With Mammographic Detection of Breast Cancer in the Ontario Breast Screening Program
- (2011) V. A. Kirsh et al. JNCI-Journal of the National Cancer Institute
- Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain
- (2010) Laia Domingo et al. CANCER CAUSES & CONTROL
- Complementary approaches to assessing risk factors for interval breast cancer
- (2010) Jan T. Lowery et al. CANCER CAUSES & CONTROL
- Tumor Characteristics in Screen-Detected and Symptomatic Breast Cancers
- (2009) István Pálka et al. PATHOLOGY & ONCOLOGY RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started